spondylarthropathies/атлусценне

Спасылка захоўваецца ў буферы абмену

Выберыце тып сартавання

Старонка 1 ад 72 вынікі

Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey

Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі

Увайсці / Зарэгістравацца

Objective: To investigate the prevalence of overweight and obesity, as well as the association between body mass index (BMI) and disease activity in patients with axial spondyloarthritis (axSpA). Methods:

The role of obesity on inflammation and damage in spondyloarthritis: a systematic literature review on body mass index and imaging.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

The objective of this systematic literature review was to evaluate the effect of obesity and/or body mass index (BMI) on radiographic findings of spondyloarthritis (SpA) for both axial and peripheral inflammation and damage.Medline, Embase and Cochrane

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

Objective: the aim of our systematic review and meta-analysis was to investigate whether overweight/obesity are associated with higher disease activity measures in axial spondyloarthritis (axSpA) patients.

Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

To determine if obesity is associated with poorer patient-reported outcomes (PROs) in patients with axial spondyloarthritis (axSpA), we conducted a cross-sectional study using data of the PRESPOND registry from a tertiary referral center in Singapore between 2011 and 2015. Demographics, clinical,

Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

To assess whether smoking and obesity are predictors of poor treatment response in patients with axial spondyloarthritis (axSpA). A systematic literature review was performed by searching in MEDLINE and EMBASE up to June 2019 with a strategy based on the PICO approach: Population: patients with

Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

OBJECTIVE To assess the prevalence of overweight and obesity in a large cohort of patients with axial spondyloarthritis (axSpA) in comparison with the general population. To explore the relationship of body mass index (BMI) with clinical outcome in axSpA. METHODS Patients from the Groningen

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

The aim of our study was to investigate the influence of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) and body mass index (BMI) on circulating drug levels and clinical response to tumour necrosis factor inhibitor (TNFi) therapy in axial spondyloarthritis

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). The aim of our study was to investigate the impact of different body mass index (BMI) categories on TNFi response in a large cohort of

Patients with Spondyloarthritis and Obesity Who Fail TNF Antagonist Therapy: Change the Subcutaneous Injection Site before the Biologic?
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

Obesity does not impair rehabilitation outcome in spondyloarthropathy.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

Objectives: To compare the prevalence and correlates of metabolic syndrome (MetS) stratified by body mass index (BMI) categories in rheumatoid arthritis (RA) and spondyloarthritis (SpA). Methods:

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: data from COMOSPA.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

To analyze the potential association between the presence of HLA-B27 and the different comorbidities observed in Axial Spondyloarthritis patients.A comparative cross-sectional study including Axial Spondyloarthritis patients from COMOSPA registry. COMOSPA

Spondyloarthritis after bariatric surgery: is there a link?
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

Presently, bariatric surgery is considered the most effective treatment for reducing excess body weight and maintaining weight loss in severely obese. On the other hand, several early and late complications have been described after this procedure. This article reports two patients who developed a

Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

In recent decades, obesity has become a public health problem in many countries. The objective of this study was to evaluate the main joint and extra-articular manifestations related to spondyloarthritis (SpA) after bariatric surgery (BS) in a retrospective

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.
Перакладаць артыкулы могуць толькі зарэгістраваныя карыстальнікі
Увайсці / Зарэгістравацца

OBJECTIVE Patients with spondyloarthritis (SpA) receiving anti-TNF-α treatment have an increase in fat mass. This may be relevant to cardiovascular risk. The aim of this study was to estimate visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) changes by dual-energy x-ray

Папярэдняя
1
2
3
4
5
Далей

Далучайцеся да нашай
старонкі ў facebook
Herbal & Natural Medicine
Самая поўная база дадзеных пра лекавыя травы, падтрыманая навукай
Працуе на 55 мовах
Лячэнне травой пры падтрымцы навукі
Распазнаванне траў па малюнку
Інтэрактыўная GPS-карта - пазначце травы па месцы (хутка)
Чытайце навуковыя публікацыі, звязаныя з вашым пошукам
Шукайце лекавыя зёлкі па іх уздзеянні
Арганізуйце свае інтарэсы і будзьце ў курсе навінавых даследаванняў, клінічных выпрабаванняў і патэнтаў
Увядзіце сімптом альбо захворванне і прачытайце пра зёлкі, якія могуць дапамагчы, набярыце траву і паглядзіце хваробы і сімптомы, супраць якіх яна выкарыстоўваецца.
* Уся інфармацыя заснавана на апублікаваных навуковых даследаваннях

spondylarthropathies/атлусценне

Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey

The role of obesity on inflammation and damage in spondyloarthritis: a systematic literature review on body mass index and imaging.

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis

Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.

Influence of smoking and obesity on treatment response in patients with axial spondyloarthritis: a systematic literature review

Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome.

Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis.

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.

Patients with Spondyloarthritis and Obesity Who Fail TNF Antagonist Therapy: Change the Subcutaneous Injection Site before the Biologic?

Obesity does not impair rehabilitation outcome in spondyloarthropathy.

The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: data from COMOSPA.

Spondyloarthritis after bariatric surgery: is there a link?

Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis.

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment.

Самая поўная база дадзеных пра лекавыя травы, падтрыманая навукай